Report
BibTex RIS Cite

Giant abdominal mass originating from the ovary.

Year 2017, Volume: 34 Issue: 3, 221 - 223, 10.07.2018

Abstract

Adnexial masses are commonly seen in gynecologic practice. Distinguishing malign from benign masses should be done for these patients. Mucinous cystadenoma is among the most common benign ovarian neoplasms. It may grow to an enormous size. Here, we report a case of mucinous cystadenoma originating from the right ovary in a 57-year-old woman.

References

  • American College of Obstetricians and Gynecologists Committee on Gynecologic Practice., 2011. Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer. Obstet Gynecol. 117-742. Buys SS, Partridge E, Greene MH, et al., 2005. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer scree ning trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 193-1630. Curtin JP., 1994. Management of the adnexal mass. Gynecol Oncol. 55-42. Guerriero S, Alcazar JL, Coccia ME, et al., 2002. Complex pelvic mass as a target of evaluation of vessel distribution by color Doppler so nography for the diagnosis of adnexal malignancies: results of a multicenter European study. J Ultrasound Med. 21-1105. Hart WR., 2005.Mucinous tumors of the ovary: a review. Int J Gynecol Pathol. 24-4.http://seer.cancer.gov/.,2012. (Accessed on September 07).Im SS, Gordon AN, Buttin BM, et al., 2005. Validation of referral guidelines for women with pelvic masses. Obstet Gynecol 105-35. Myers ER, Bastian LA, Havrilesky LJ, et al., 2006. Management of Adnexal Mass. Evidence Report/Technology Assessment No.130 (Prepared by the Duke Evidence-based Practice Center under Contract No. 290-02-0025). AHRQ Publication No. 06-E004, Agency for Healthcare Research and Quality, Rockville, MD February. Ozols RF, Rubin SC, Thomas GM et al., 2005. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, Barakat RR, Markman M, Randall ME, eds. Principles and Practice of Gynecologic Oncology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins. 910–911. Riopel MA, Ronnett BM, Kurman RJ., 1999. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypi cal proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol. 23-617. Roman LD, Muderspach LI, Stein SM, et al., 1997. Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer. Obstet Gynecol 89-493. SS, Keklik E, Greene MH, vd Buys., 2005. Prostat, Akciğer, Kolorektal ve Over (PLCO) kanser tarama çalışmasında Yumurtalık kanseri tara ması: randomize bir çalışmada ilk ekrandan bulgular. Am J Obstet Gynecol 1630-193. Vang R, Gown AM, Farinola M, et al., 2007. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocar cinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Am J Surg Pathol. 31-653. Isik et al.
Year 2017, Volume: 34 Issue: 3, 221 - 223, 10.07.2018

Abstract

References

  • American College of Obstetricians and Gynecologists Committee on Gynecologic Practice., 2011. Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer. Obstet Gynecol. 117-742. Buys SS, Partridge E, Greene MH, et al., 2005. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer scree ning trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol. 193-1630. Curtin JP., 1994. Management of the adnexal mass. Gynecol Oncol. 55-42. Guerriero S, Alcazar JL, Coccia ME, et al., 2002. Complex pelvic mass as a target of evaluation of vessel distribution by color Doppler so nography for the diagnosis of adnexal malignancies: results of a multicenter European study. J Ultrasound Med. 21-1105. Hart WR., 2005.Mucinous tumors of the ovary: a review. Int J Gynecol Pathol. 24-4.http://seer.cancer.gov/.,2012. (Accessed on September 07).Im SS, Gordon AN, Buttin BM, et al., 2005. Validation of referral guidelines for women with pelvic masses. Obstet Gynecol 105-35. Myers ER, Bastian LA, Havrilesky LJ, et al., 2006. Management of Adnexal Mass. Evidence Report/Technology Assessment No.130 (Prepared by the Duke Evidence-based Practice Center under Contract No. 290-02-0025). AHRQ Publication No. 06-E004, Agency for Healthcare Research and Quality, Rockville, MD February. Ozols RF, Rubin SC, Thomas GM et al., 2005. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, Barakat RR, Markman M, Randall ME, eds. Principles and Practice of Gynecologic Oncology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins. 910–911. Riopel MA, Ronnett BM, Kurman RJ., 1999. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypi cal proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol. 23-617. Roman LD, Muderspach LI, Stein SM, et al., 1997. Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer. Obstet Gynecol 89-493. SS, Keklik E, Greene MH, vd Buys., 2005. Prostat, Akciğer, Kolorektal ve Over (PLCO) kanser tarama çalışmasında Yumurtalık kanseri tara ması: randomize bir çalışmada ilk ekrandan bulgular. Am J Obstet Gynecol 1630-193. Vang R, Gown AM, Farinola M, et al., 2007. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocar cinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Am J Surg Pathol. 31-653. Isik et al.
There are 1 citations in total.

Details

Primary Language English
Journal Section Surgery Medical Sciences
Authors

Yüksel Işık

Publication Date July 10, 2018
Submission Date September 10, 2015
Acceptance Date November 2, 2015
Published in Issue Year 2017 Volume: 34 Issue: 3

Cite

APA Işık, Y. (2018). Giant abdominal mass originating from the ovary. Journal of Experimental and Clinical Medicine, 34(3), 221-223.
AMA Işık Y. Giant abdominal mass originating from the ovary. J. Exp. Clin. Med. July 2018;34(3):221-223.
Chicago Işık, Yüksel. “Giant Abdominal Mass Originating from the Ovary”. Journal of Experimental and Clinical Medicine 34, no. 3 (July 2018): 221-23.
EndNote Işık Y (July 1, 2018) Giant abdominal mass originating from the ovary. Journal of Experimental and Clinical Medicine 34 3 221–223.
IEEE Y. Işık, “Giant abdominal mass originating from the ovary”., J. Exp. Clin. Med., vol. 34, no. 3, pp. 221–223, 2018.
ISNAD Işık, Yüksel. “Giant Abdominal Mass Originating from the Ovary”. Journal of Experimental and Clinical Medicine 34/3 (July 2018), 221-223.
JAMA Işık Y. Giant abdominal mass originating from the ovary. J. Exp. Clin. Med. 2018;34:221–223.
MLA Işık, Yüksel. “Giant Abdominal Mass Originating from the Ovary”. Journal of Experimental and Clinical Medicine, vol. 34, no. 3, 2018, pp. 221-3.
Vancouver Işık Y. Giant abdominal mass originating from the ovary. J. Exp. Clin. Med. 2018;34(3):221-3.